Larvol Delta - Results-from-the-core-phase-of-the-openlabel-Phase-3-ACROINNOVA-2-trial-CAM2029-a-subcutaneous-octreotide-depot-achieves-sustained-longterm-biochemical-control-in-acromegaly

Oclaiz (octreotide subcutaneous depot) - Camurus

https://ese-hormonesapps.m-anage.com/espeese25/en-GB/pag/presentation/494118

Joanna L. Spencer-Segal

Apr 10, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next